Clinical Trial

Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This prospective, randomized controlled trial aims to investigate the perioperative use of lemborexant, an orexin receptor antagonist, for reducing postoperative delirium (POD) in elderly patients undergoing general anesthesia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-06.
Trial Details
NCT Number NCT07695285
Lead Sponsor Beijing Tiantan Hospital
Conditions Postoperative Delirium
Enrollment 992 participants
Start Date 2026-09-01
Primary Completion 2029-09-01 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14